Champions Oncology (CSBR) Return on Capital Employed Growth (1y) (2012 - 2026)
Champions Oncology (CSBR) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn | -7,428.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -7,428.00 |
| Jan 31, 2026 | -10,842.00 |
| Oct 31, 2025 | 3,882.00 |
| Jul 31, 2025 | 8,538.00 |
| Apr 30, 2025 | 20,919.00 |
| Jan 31, 2025 | 25,039.00 |
| Oct 31, 2024 | 10,375.00 |
| Jul 31, 2024 | 961.00 |
| Apr 30, 2024 | -11,060.00 |
| Jan 31, 2024 | -15,269.00 |
| Oct 31, 2023 | -11,785.00 |
| Jul 31, 2023 | -6,689.00 |
| Apr 30, 2023 | -4,251.00 |
| Jan 31, 2023 | -2,140.00 |
| Oct 31, 2022 | -114.00 |
| Jul 31, 2022 | 170.00 |
| Apr 30, 2022 | 117.00 |
| Jan 31, 2022 | 880.00 |
| Oct 31, 2021 | 1,617.00 |
| Jul 31, 2021 | 1,301.00 |